Press Releases about Foghorn Therapeutics Inc
Foghorn Therapeutics to Participate in the BMO Oncology Summit
October 01, 2024
Via GlobeNewswire
Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor
February 08, 2024
Via GlobeNewswire
Foghorn Therapeutics Announces CFO Departure
January 03, 2024
Via GlobeNewswire
Via GlobeNewswire
Foghorn Therapeutics Announces Chief Medical Officer Succession
August 08, 2023
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
922 Allowance Ave SE
Medicine Hat, AB T1A 3G7
Office hours: 8:30 a.m.-4:30 p.m. Monday to Friday, closed Saturday Sunday and statutory holidays.
[P] 403.527.1101
[F] 403-527-0737